Gottemukkala K, Chrustowicz J, Sherpa D, Sepic S, Vu D, Karayel O
Mol Cell. 2024; 84(10):1948-1963.e11.
PMID: 38759627
PMC: 7616709.
DOI: 10.1016/j.molcel.2024.04.014.
Sepulveda C, Garcia C, Damonte E
Microorganisms. 2022; 10(8).
PMID: 36014049
PMC: 9413629.
DOI: 10.3390/microorganisms10081631.
Naffouje R, Grover P, Yu H, Sendilnathan A, Wolfe K, Majd N
Cancers (Basel). 2019; 11(9).
PMID: 31514446
PMC: 6770829.
DOI: 10.3390/cancers11091346.
Midtkandal R, Redpath P, Trammell S, Macdonald S, Brenner C, Migaud M
Bioorg Med Chem Lett. 2012; 22(16):5204-7.
PMID: 22795628
PMC: 3683580.
DOI: 10.1016/j.bmcl.2012.06.069.
Usha V, Hobrath J, Gurcha S, Reynolds R, Besra G
PLoS One. 2012; 7(3):e33886.
PMID: 22479467
PMC: 3315515.
DOI: 10.1371/journal.pone.0033886.
Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: new insights on structure and function relationship.
Brunetti L, Di Stefano M, Ruggieri S, Cimadamore F, Magni G
Protein Sci. 2010; 19(12):2440-50.
PMID: 20954240
PMC: 3009411.
DOI: 10.1002/pro.526.
IMP dehydrogenase: structure, mechanism, and inhibition.
Hedstrom L
Chem Rev. 2009; 109(7):2903-28.
PMID: 19480389
PMC: 2737513.
DOI: 10.1021/cr900021w.
Characterization of human brain nicotinamide 5'-mononucleotide adenylyltransferase-2 and expression in human pancreas.
Yalowitz J, Xiao S, Biju M, Antony A, Cummings O, Deeg M
Biochem J. 2003; 377(Pt 2):317-26.
PMID: 14516279
PMC: 1223862.
DOI: 10.1042/BJ20030518.
Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair.
Boulton S, Kyle S, Durkacz B
Br J Cancer. 1997; 76(7):845-51.
PMID: 9328141
PMC: 2228057.
DOI: 10.1038/bjc.1997.473.
Tiazofurin: a new antitumor agent.
ODwyer P, Shoemaker D, Jayaram H, Johns D, Cooney D, Marsoni S
Invest New Drugs. 1984; 2(1):79-84.
PMID: 6381381
DOI: 10.1007/BF00173791.
Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.
Huggins J, ROBINS R, Canonico P
Antimicrob Agents Chemother. 1984; 26(4):476-80.
PMID: 6151377
PMC: 179947.
DOI: 10.1128/AAC.26.4.476.
Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.
Raghavan D, Bishop J, Sampson D, Grygiel J, Woods R, Coates A
Cancer Chemother Pharmacol. 1986; 16(2):160-4.
PMID: 3948303
DOI: 10.1007/BF00256168.
Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
Berger N, Berger S, Catino D, Petzold S, ROBINS R
J Clin Invest. 1985; 75(2):702-9.
PMID: 3919063
PMC: 423562.
DOI: 10.1172/JCI111750.
Clinical pharmacology of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
Green R, Stewart D, Maroun J
Invest New Drugs. 1986; 4(4):387-94.
PMID: 3583646
DOI: 10.1007/BF00173513.
Studies of purine and tiazofurin metabolism in drug sensitive human chronic myelogenous leukemia K 562 cells.
Pillwein K, Jayaram H, Weber G
Blut. 1988; 57(2):97-100.
PMID: 3165681
DOI: 10.1007/BF00319733.
Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
Olah E, Natsumeda Y, Ikegami T, Kote Z, Horanyi M, Szelenyi J
Proc Natl Acad Sci U S A. 1988; 85(17):6533-7.
PMID: 2901100
PMC: 282007.
DOI: 10.1073/pnas.85.17.6533.
Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
Carney D, AHLUWALIA G, Jayaram H, Cooney D, Johns D
J Clin Invest. 1985; 75(1):175-82.
PMID: 2856924
PMC: 423424.
DOI: 10.1172/JCI111671.
Phase I study of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
Maroun J, Stewart D
Invest New Drugs. 1990; 8 Suppl 1:S33-9.
PMID: 2380015
DOI: 10.1007/BF00171982.
Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Jayaram H, Murayama K, Pillwein K, Zhen W, Weber G
Cancer Chemother Pharmacol. 1992; 31(2):93-6.
PMID: 1451238
DOI: 10.1007/BF00685093.
